Beyond Air, Inc. (XAIR)
Stock Price:
$7.07 USD
0.26 (3.82%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
119.07M |
| Revenue (ttm) |
1.39M |
| Net Income (ttm) |
20.99M |
| Shares Out |
16.45M |
| EPS (ttm) |
-1.53 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 2, 2020 |
| Last Price |
$7.07 |
| Previous Close |
$6.81 |
| Change ($) |
0.26 |
| Change (%) |
3.82% |
| Day's Open |
6.90 |
| Day's Range |
6.70 - 7.20 |
| Day's Volume |
361,171 |
| 52-Week Range |
3.45 - 12.50 |
More Stats
| Market Cap |
119.07M |
| Enterprise Value |
98.48M |
| Earnings Date (est) |
Aug 12, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
16.45M |
| Float |
10.81M |
| EPS (basic) |
-1.78 |
| EPS (diluted) |
-1.53 |
| FCF / Share |
-1.33 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
1.46M |
| Short Ratio |
6.13 |
| Short % of Float |
9.88% |
| Beta |
-0.61 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
85.66 |
| PB Ratio |
9.51 |
| Revenue |
1.39M |
| Operating Income |
-18.14M |
| Net Income |
20.99M |
| Free Cash Flow |
-15.29M |
| Net Cash |
20.59M |
| Net Cash / Share |
1.22 |
| Gross Margin |
100.00% |
| Operating Margin |
-1,305.08% |
| Profit Margin |
1,472.20% |
| FCF Margin |
-1,100.18% |
| ROA |
-61.52% |
| ROE |
-180.33% |
| ROIC |
397.40% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
4 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$13.25*
(87.41% upside)
Low
9.00
Current: 7.07
High
17.00
Target: 13.25
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 1.39 | 7.72 | - | - |
| Revenue Growth | -82% | - | - | - |
| Gross Profit | 1.39 | 7.72 | - | - |
| Operating Income | -18.14 | -3.06 | -11.07 | -2.33 |
| Net Income | 20.99 | -6.56 | -18.04 | 3.72 |
| Shares Outstanding | 11.51 | 8.50 | 6.00 | 1.45 |
| Earnings Per Share | -1.78 | -0.77 | -3.01 | -2.69 |
| Operating Cash Flow | -15.25 | 1.34 | -7.12 | -0.69 |
| Capital Expenditures | -0.04 | -0.06 | -0.24 | 0.01 |
| Free Cash Flow | -15.29 | 1.28 | -7.36 | -0.68 |
| Cash & Equivalents | 25.47 | 7.90 | 1.81 | 0.01 |
| Total Debt | 4.88 | 0.26 | 0.03 | 3.31 |
| Net Cash / Debt | 20.59 | 7.64 | 1.78 | -3.31 |
| Assets | 27.43 | 9.43 | 2.19 | 0.24 |
| Liabilities | 9.34 | 5.40 | 10.57 | 4.93 |
| Book Value | 18.09 | 4.02 | -8.38 | -4.70 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Beyond Air, Inc. |
| Country |
United States |
| Employees |
18 |
| CEO |
Steven A. Lisi |
Stock Information
| Ticker Symbol |
XAIR |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: XAIR |
Description
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.